Saad Harti
CEO, Chairman
Switzerland
Saad has started in the financial field, at Arthur Andersen. He later co-founded Altacare, a healthcare business development firm active in more than 50 markets. Saad has pioneered contraceptive-access programs in developing countries. Saad is the founder of Legacy Healthcare and manages the company.

Jiawei Liu PhD
Head of R&D, Drug Discovery
Switzerland
Dr. JiaWei Liu’s expertise lies in molecular biology, dermatology, cardiovascular and oncology domains, with over 20 years’ preclinical and clinical research and teaching experience at high ranking academic institutes (Universities and Hospitals Geneva, Lausanne, Harvard Medical School, Shanghai Institute of Materia Medica) and pharmaceutical companies (Debiopharm and Astellas). In addition to numerous peer-reviewed scientific publications, he is the co-inventor of several U.S. and worldwide patents that hold high potential commercial value.

Michel Chrétienne
PharmD
Director of Quality Pharmaceutical Development
France
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi). He then spent more than 10 years at HRA Pharma, a specialty pharma, as Qualified person in charge of Quality System and batch release.

Nadine Vincent
PharmD
Head of Regulatory Affairs
France
Dr. Nadine Vincent, PharmD is a pharmacist with 40 years’ experience in Regulatory Affairs at large pharma and medium-sized biotechs. Nadine has contributed to achieving FDA and EMA approval for 6 drugs.

Bruce Patsner MD, JD
Medical
US
Bruce Patsner M.D. J.D. is a cancer surgeon, law Professor and former Senior Medical Officer at FDA with more than 15 years Pharma experience in clinical trial design, new prescription drug approval and pharmacovigilance, and regulation of drugs, devices, and biologics. While at FDA he was responsible for the approval of several new prescription drugs in women’s health and Oncology and reviewed more than 50 INDs. He is also a current member of the Editorial Board of the prestigious law journal Food and Drug Law.

Saad Harti
Founder & Chairman
Switzerland
Saad has started in the financial field, at Arthur Andersen.He later co-founded Altacare, a healthcare business development firm active in more than 50 markets. Saad has pioneered contraceptive-access programs in developing countries. Saad is the founder of Legacy and manages the company.

Alexandre Guichard
Clinical
Switzerland
Dr. Alexandre Guichard, PharmD, Ph D is an expert in dermatology, having participated in several clinical trials focusing on scalp disorders. Prior to Legacy Healthcare, Dr. Guichard was the manager and founder of the Trichology Unit at Besançon University Hospital (FR)

Cécile Bernier
Production & Developement Manager
Switzerland
Cécile Bernier is an expert in formulation and manufacturing and has over 10 years’ experience in developing formulations. She oversaw already the manufacturing of 125 industrial batches of Coacillium during pre-marketing period.

Angelo Mello
Head of Corporate Development
Switzerland
Senior International Business Manager, with 25+ years of experience in International Business Development,
Alliance Management, Market Access and Marketing in the pharmaceutical and Life Science industry. Experience acquired internationally (Brazil, Mexico and Switzerland)

Chris Cambourg
IT & Technical Director
Switzerland
Around 20 years career in the pharma industry with broad experience in the IT & Technology field. Chris Cambourg is an expert devising and establishing IT policies and systems to support the implementation of strategies set by the company.

Tatiana Rossetti
Head of Clinical Operations
Switzerland
Senior Clinical Development Professional with a 26-year history of working in the pharmaceutical industry. Extensive expertise in strategic planning for new drug development from a Clinical Operational perspective. A proven track record of success in global international programs, working in both contract research organizations (CROs) and biopharmaceutical companies, and achieving successful FDA and EMA drug marketing approvals.

Sandra Gumy
Senior Clinical Operations Manager
Switzerland
With over 20 years' experience in clinical trial development in a range of therapeutic areas including neurology, oncology and women's health. Involving the management of clinical studies, in particular through close collaboration with contract research organizations (CROs) and third-party suppliers, as well as preparation for inspections by the competent authorities.

Emmanuel Baert
Country Manager France
France
Emmanuel has almost 25 years of experience in pharmaceutical particularly in rare disease. He managed the operations in France (LFB Biomedicaments , Menarini Hospital for Melinta therapeutics) and launched activities in Latin America (LFB Biomedicaments, Servier). Today, he is Country Manager France, coordinates the European market access and pre-launch..

Marcos Val
CFO
Switzerland
Marcos spent 15 years in Healthcare and FMCG blue-chip corporates. Within biopharma, as Medtronic director, he did launch multi-million revenue programs. He later built a track-record raising funds for startups and carrying due diligence work for impact, until joining Legacy in 2017.

Tadafumi Shiiba
Country Manager
Japan
Tadafumi Shiiba, General Manager for Legacy Healthcare KK (Japan), has been working for medical corporations for more than 20 years with experiencing to manage two clinical trials on the product in Japan

Amit Srivastava
India operations
India

Amit Srivastava is a pharmacist and MBA with over 25 years’ experience in business management with large pharmaceuticals and nutraceuticals companies at C’ suite level. Amit has also set up world’s first and largest biotech and nutratech start up incubation hub for government of India as director on board and CEO.

Pr.William Pralong
MD PhD
Chief Scientific Officer
Switzerland
Prof. em. EPLF, Bioengineering, QAQC
Scientific Advisor for Quality and Research

Geert Cauwenbergh
PhD
Director
US
Geert founded Barrier Therapeutics, a dermatology company, in 2001 which he took public in 2004. After bringing Barrier to success, it was acquired by Stiefel/GSK in 2008. Afterwards, he became CEO of RXi Pharma/Phio, a dermatology and immune-oncology company, which he took public in 2012. Prior to founding Barrier, Geert was responsible for the worldwide R&D dermatology at J&J. He is a board member of several dermatology companies and has authored more than 100 publications.

Johanne Barthelet
Director
Switzerland
Johanne started as a consultant, including with PWC Transaction Services division. She took-over and successfully turned-around a Swiss specialty-logistics and international transport company, until she divested it.

Bernard Lignon
Director
Bernard started his career in pharma sales and marketing. He managed the European and African affiliates of several pharmaceutical firms (Sanofi, Akzo, etc.). He has been in charge of the communication of Pierre Fabre, one the largest independent European pharma, and a pioneer of botanical-based treatment and oncology.

Michel Chrétienne PharmD
Director
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi).

Dr. med. Ulrike Blume-Peytavi
Germany
Investigator
Clinical Research Centre for Hair and Skin approach Charité-Universitätsmedizin

Juhee Cho
PhD
Investigator
Korea
Investigator for Permanent Chemotherapy-Induced Alopecia

Dr. Khalil Zaman
Investigator
Switzerland
CHUV- Investigator for Chemotherapy-Induced Alopecia

Prof. Bianca Maria Piraccini
Investigator
Italy
University of Bologna Dermatology Department of Specialized, Experimental and Diagnostic Medicine.

Dr. Leorey N. Saligan
Investigator
US
Maryland, US National Institutes of Health
Investigator for Cancer-Related Fatigue

Yasuyuki Kojima, MD, PhD
Investigator
Japan
St Marianna University School of Medicine
Investigator for Chemotherapy-Induced Alopecia trial

Pr. Kurt Hostettman
Advisor
Switzerland
Prof.em. UniGe and Unil, Pharmacy
Scientific Advisor for development of New Botanical Entities

Dr Liliane Laroche
Advisor
France
Michel has served as Pharmaceutical Director and Pharmacist in charge at Hoechst Marion Roussel (Aventis) until 1999. Michel is involved in a number of professional and scientific societies such as the French Association of Regulatory Affairs, Member of the Ethic Committee and Mediation of the French pharmaceutical industry (CEMIP) etc. Michel is responsible of the quality and manufacturing affairs of Legacy.

Bruno David
PhD, DPharm Advisor
France
Bruno is a phytochemist who had an academic and an industrial pharmaceutical career. He was Director of Natural products drug discovery at Pierre Fabre Laboratories over 30 years. He is member of the French National Academy of Pharmacy.